Ward, J. F., Slezak, J. M., Blute, M. L., Bergstralh, E. J., & Zincke, H. (2005). Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome. BJU international, 95(6), 751-756. https://doi.org/10.1111/j.1464-410X.2005.05394.x
Chicago Style (17th ed.) CitationWard, John F., Jeffrey M. Slezak, Michael L. Blute, Erik J. Bergstralh, and Horst Zincke. "Radical Prostatectomy for Clinically Advanced (cT3) Prostate Cancer Since the Advent of Prostate‐specific Antigen Testing: 15‐year Outcome." BJU International 95, no. 6 (2005): 751-756. https://doi.org/10.1111/j.1464-410X.2005.05394.x.
MLA (9th ed.) CitationWard, John F., et al. "Radical Prostatectomy for Clinically Advanced (cT3) Prostate Cancer Since the Advent of Prostate‐specific Antigen Testing: 15‐year Outcome." BJU International, vol. 95, no. 6, 2005, pp. 751-756, https://doi.org/10.1111/j.1464-410X.2005.05394.x.